Stephens Investment Management Group LLC reduced its holdings in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) by 27.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 184,321 shares of the company’s stock after selling 70,675 shares during the quarter. Stephens Investment Management Group LLC owned approximately 0.11% of Astera Labs worth $65,613,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. BlackRock Inc. acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $6,609,581,000. ABS Investment Management LLC bought a new position in shares of Astera Labs during the second quarter worth approximately $1,980,382,000. Van ECK Associates Corp grew its holdings in Astera Labs by 20.0% in the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after buying an additional 373,545 shares in the last quarter. Bank of America Corp DE bought a new position in Astera Labs during the 2nd quarter worth $1,061,791,000. Finally, Atreides Management LP acquired a new stake in shares of Astera Labs during the second quarter worth $587,736,000. Institutional investors and hedge funds own 60.47% of the company’s stock.
Astera Labs Stock Up 2.4%
NASDAQ:ALAB opened at $216.75 on Thursday. The firm has a market capitalization of $37.88 billion, a PE ratio of 86.35 and a beta of 3.85. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48. The stock’s 50-day simple moving average is $288.88 and its 200 day simple moving average is $257.84.
Insider Buying and Selling at Astera Labs
In related news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the sale, the director owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction dated Thursday, November 5th. The shares were sold at an average price of $211.41, for a total value of $1,901,421.54. Following the completion of the transaction, the director owned 1,987 shares of the company’s stock, valued at $420,071.67. This represents a 81.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 417,090 shares of company stock worth $102,663,347 over the last three months. 10.40% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
ALAB has been the topic of a number of recent research reports. Zacks Research lowered shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 5th. BMO Capital Markets began coverage on shares of Astera Labs in a research report on Thursday, November 5th. They issued an “outperform” rating and a $375.00 price target for the company. Roth Capital reiterated a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Wall Street Zen upgraded Astera Labs from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Finally, Susquehanna dropped their price objective on Astera Labs from $310.00 to $258.00 and set a “neutral” rating for the company in a report on Wednesday, November 4th. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, Astera Labs has an average rating of “Moderate Buy” and an average price target of $320.85.
Read Our Latest Analysis on Astera Labs
Astera Labs News Summary
Here’s some of the latest news about ALAB:
- Positive Sentiment: Astera Labs expanded its collaboration with Hyve Solutions, integrating its Orion Compute Board, Fabric Tray and Link Board into Hyve’s Apex platform. The pre-validated systems aim to speed AI rack deployment and give enterprise and neocloud customers flexibility as accelerator needs grow. Article: How Does Astera Labs’ New AI Infrastructure Partnership Change Its Enterprise Opportunity?
- Negative Sentiment: Recent market coverage describes ALAB’s rebound as technically fragile. The shares are below their reported 50-day and 200-day moving averages, while several analysts have lowered price targets after the earnings report—potential headwinds despite the strong results. Article: Record Q3 Growth Meets a Shaky Rebound
- Negative Sentiment: ETFs were reported as net sellers of Astera Labs shares, which could add to near-term selling pressure. Article: ETFs Are Net Sellers of Astera Labs
Astera Labs Profile
Astera Labs, Inc. is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help move data among processors, accelerators, memory and other components in high-performance computing systems. The company’s portfolio includes Aries PCIe and CXL retimers, Taurus Ethernet smart cable modules, Scorpio fabric switches and Leo CXL memory connectivity controllers. Astera Labs also offers software tools to help customers configure and monitor its connectivity products.
Recommended Stories
- Five stocks we like better than Astera Labs
- Target Stock Is Up Over 70%—Has the Easy Money Already Been Made?
- Amazon’s Zoox Just Joined Uber—Could That Change the Robotaxi Threat?
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.
